FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

2843411000001106: Relifex 500mg dispersible tablets (Meda Pharmaceuticals Limited) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
17231101000001110 Relifex 500mg dispersible tablets (Meda Pharmaceuticals Limited) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
38105701000001114 Relifex 500mg dispersible tablets (Meda Pharmaceuticals Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Relifex 500mg dispersible tablets (Meda Pharmaceuticals Limited) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Relifex 500mg dispersible tablets (Meda Pharmaceuticals Limited) Is a Nabumetone 500mg dispersible tablet false Inferred relationship Existential restriction modifier
Relifex 500mg dispersible tablets (Meda Pharmaceuticals Limited) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Relifex 500mg dispersible tablets (Meda Pharmaceuticals Limited) Is a Nabumetone 500mg dispersible tablets sugar free true Inferred relationship Existential restriction modifier
Relifex 500mg dispersible tablets (Meda Pharmaceuticals Limited) Has NHS dm+d (dictionary of medicines and devices) freeness indicator Sugar free true Inferred relationship Existential restriction modifier
Relifex 500mg dispersible tablets (Meda Pharmaceuticals Limited) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Relifex 500mg dispersible tablets (Meda Pharmaceuticals Limited) Is a Nabumetone 500mg dispersible tablets sugar free false Inferred relationship Existential restriction modifier
Relifex 500mg dispersible tablets (Meda Pharmaceuticals Limited) Has dispensed dose form Dispersible tablet true Inferred relationship Existential restriction modifier
Relifex 500mg dispersible tablets (Meda Pharmaceuticals Limited) Has active ingredient Nabumetone true Inferred relationship Existential restriction modifier
Relifex 500mg dispersible tablets (Meda Pharmaceuticals Limited) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Relifex 500mg dispersible tablets (Meda Pharmaceuticals Limited) VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Relifex 500mg dispersible tablets (Meda Pharmaceuticals Limited) Has manufactured dose form Dispersible tablet false Inferred relationship Existential restriction modifier
Relifex 500mg dispersible tablets (Meda Pharmaceuticals Limited) Is a Relifex true Inferred relationship Existential restriction modifier
Relifex 500mg dispersible tablets (Meda Pharmaceuticals Limited) Has specific active ingredient Nabumetone true Inferred relationship Existential restriction modifier
Relifex 500mg dispersible tablets (Meda Pharmaceuticals Limited) Has dispensed dose form Dispersible tablet false Inferred relationship Existential restriction modifier
Relifex 500mg dispersible tablets (Meda Pharmaceuticals Limited) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Relifex 500mg dispersible tablets (Meda Pharmaceuticals Limited) Has manufactured dose form Dispersible tablet true Inferred relationship Existential restriction modifier
Relifex 500mg dispersible tablets (Meda Pharmaceuticals Limited) Has dispensed dose form Dispersible tablet false Inferred relationship Existential restriction modifier
Relifex 500mg dispersible tablets (Meda Pharmaceuticals Limited) Has dispensed dose form Dispersible tablet false Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Relifex 500mg dispersible tablets (Meda Pharmaceuticals Limited) 60 tablet 6 x 10 tablets Is pack of False Relifex 500mg dispersible tablets (Meda Pharmaceuticals Limited) Inferred relationship Existential restriction modifier
Relifex 500mg dispersible tablets (Meda Pharmaceuticals Limited) 10 tablet Is pack of False Relifex 500mg dispersible tablets (Meda Pharmaceuticals Limited) Inferred relationship Existential restriction modifier
Relifex 500mg dispersible tablets (Meda Pharmaceuticals Limited) 60 tablet 6 x 10 tablets Has AMP True Relifex 500mg dispersible tablets (Meda Pharmaceuticals Limited) Inferred relationship Existential restriction modifier
Relifex 500mg dispersible tablets (Meda Pharmaceuticals Limited) 10 tablet Has AMP True Relifex 500mg dispersible tablets (Meda Pharmaceuticals Limited) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start